Literature DB >> 8042189

Growth factors for human pleural mesothelial cells in soluble products from formed clots.

D E Griffith1, A R Johnson, A Kumar, D B Holiday, S Idell.   

Abstract

Fibrin deposition within the pleural space may influence repair following pleural injury. Although the mesothelial surface can organize fibrin, the contribution of pleural mesothelial cells to pleural repair is unknown. During coagulation thrombin cleaves Fibrinopeptide A (FPA, A alpha 1-16) and fibrinopeptide B (FPB) from the A alpha and B beta chains of fibrinogen to generate fibrin monomer. Since these peptides are mitogenic for human fibroblasts, we considered that they might stimulate replication of human pleural mesothelial cells (HPMC). Application of fluid expressed from fibrin clots significantly increased cell number and stimulated uptake of 3H-thymidine by HPMC compared with untreated cells. The mitogenic response of subconfluent HPMC to dilutions of clot fluid (30-150 micrograms/ml protein) was comparable to that of 0.1 nM TGF-beta. Fibrinopeptide A (7.5-30 microM) stimulated 3H-thymidine uptake in HPMC, but FPB had only a slight effect at 30 microM. Antibody to FPA antibody significantly attenuated the mitogenic effect of clot fluid, indicating that a major component is FPA. Our study suggests that fibrinopeptides released during fibrin formation in vivo may stimulate local mesothelial regeneration following pleural injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8042189     DOI: 10.1016/0049-3848(94)90109-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

Review 1.  The mesothelial cell and its role in asbestos-induced pleural injury.

Authors:  M Kuwahara; E Kagan
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

2.  Role of talc modulation on cytokine activation in cancer patients undergoing pleurodesis.

Authors:  Yehuda Schwarz; Alex Star
Journal:  Pulm Med       Date:  2012-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.